These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 6599674)
21. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats. Stallone JN Am J Physiol; 1995 Jan; 268(1 Pt 2):R40-9. PubMed ID: 7840337 [TBL] [Abstract][Full Text] [Related]
22. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid. Aydin C; Yalcin M Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):361-8. PubMed ID: 18571395 [TBL] [Abstract][Full Text] [Related]
23. Involvement of arginine vasopressin in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats. Jochem J Inflamm Res; 2004 Jul; 53(7):269-76. PubMed ID: 15241560 [TBL] [Abstract][Full Text] [Related]
24. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism. Yalcin M; Aydin C Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598 [TBL] [Abstract][Full Text] [Related]
25. Systemic vascular effects of cyclosporin A treatment in normotensive rats. Rego A; Vargas R; Cathapermal S; Kuwahara M; Foegh ML; Ramwell PW J Pharmacol Exp Ther; 1991 Nov; 259(2):905-15. PubMed ID: 1941635 [TBL] [Abstract][Full Text] [Related]
26. Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats. Mimura Y; Ogura T; Yamauchi T; Otsuka F; Oishi T; Harada K; Hashimoto M; Ota Z Acta Med Okayama; 1995 Aug; 49(4):187-94. PubMed ID: 7502678 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: the investigation of peripheral mechanisms. Yalcin M; Savci V Neuropeptides; 2007 Dec; 41(6):465-75. PubMed ID: 17897713 [TBL] [Abstract][Full Text] [Related]
28. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat. Nagahama S; Chen YF; Lindheimer MD; Oparil S J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141 [TBL] [Abstract][Full Text] [Related]
29. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat. Nagahama S; Chen YF; Lindheimer MD; Oparil S J Pharmacol Exp Ther; 1986 Nov; 239(2):426-32. PubMed ID: 3772802 [TBL] [Abstract][Full Text] [Related]
30. Vasopressin and angiotensin receptors of the medial septal area in the control of mean arterial pressure induced by vasopressin. Pavan de Arruda Camargo GM; Abrão Saad W; de Arruda Camargo LA J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):133-8. PubMed ID: 18957383 [TBL] [Abstract][Full Text] [Related]
31. Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats. Januszewicz A; Loń S; Lapiński M; Styś A J Physiol Pharmacol; 1994 Mar; 45(1):105-19. PubMed ID: 8043901 [TBL] [Abstract][Full Text] [Related]
32. Central cardiovascular effects of AVP and ANP in normotensive and spontaneously hypertensive rats. Stepniakowski K; Budzikowski A; Loń S; Szczepańska-Sadowska E J Auton Nerv Syst; 1994 Apr; 47(1-2):33-43. PubMed ID: 8188982 [TBL] [Abstract][Full Text] [Related]
33. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats. Park CG; Leenen FH J Korean Med Sci; 2001 Oct; 16(5):553-7. PubMed ID: 11641522 [TBL] [Abstract][Full Text] [Related]
34. Central and peripheral cardiovascular effects of beta-endorphin in normotensive and spontaneously hypertensive rats and in rats rendered hypertensive by deoxycorticosterone acetate administration. Rossi F; Lampa E; Berrino L; Di Giaimo A; Marmo E Res Commun Chem Pathol Pharmacol; 1987 Feb; 55(2):181-92. PubMed ID: 2950576 [TBL] [Abstract][Full Text] [Related]
35. The effects of centrally administered dexmedetomidine on cardiovascular and sympathetic function in conscious rats. Shirasaka T; Qiu DL; Kannan H; Takasaki M Anesth Analg; 2007 Dec; 105(6):1722-8, table of contents. PubMed ID: 18042874 [TBL] [Abstract][Full Text] [Related]
36. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats. Tarpey SB; Bennett T; Randall MD; Gardiner SM Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732 [TBL] [Abstract][Full Text] [Related]
37. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats. Maione S; Vitagliano S; Berrino L; Lampa E; Rossi F Neuropharmacology; 1992 Apr; 31(4):403-7. PubMed ID: 1355901 [TBL] [Abstract][Full Text] [Related]
38. Differential cardiovascular effects of centrally administered vasopressin in conscious Long Evans and Brattleboro rats. Harland D; Gardiner SM; Bennett T Circ Res; 1989 Oct; 65(4):925-33. PubMed ID: 2791228 [TBL] [Abstract][Full Text] [Related]
39. Possible involvement of beta-endorphin in the deteriorating effect of arginine vasopressin on burn shock in rats. Sun K; Lin BC; Zhang C; Wang CH; Zhu HN Circ Shock; 1989 Nov; 29(3):167-74. PubMed ID: 2591029 [TBL] [Abstract][Full Text] [Related]
40. Role of brain cholinergic system in the antihypertensive effect of clonidine in different models of rat hypertension. Squadrito F; Quattrone G; Buemi M; Frisina N; Caputi AP; Squadrito G J Hypertens Suppl; 1985 Dec; 3(4):S97-9. PubMed ID: 3868718 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]